comparemela.com

Latest Breaking News On - Hedge funds weigh in on laboratory co - Page 1 : comparemela.com

Laboratory Co of America (NYSE:LH) Raised to Buy at StockNews com

StockNews.com upgraded shares of Laboratory Co. of America (NYSE:LH – Free Report) from a hold rating to a buy rating in a research note published on Monday morning. Several other research firms also recently commented on LH. Leerink Partnrs reissued an outperform rating on shares of Laboratory Co. of America in a research report on […]

Laboratory Co of America (NYSE:LH) Updates FY24 Earnings Guidance

Laboratory Co. of America (NYSE:LH – Get Free Report) updated its FY24 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $14.30-$15.40 for the period, compared to the consensus estimate of $14.62. Laboratory Co. of America Stock Down 2.5 % LH stock opened at $216.64 on Friday. The company has a […]

Laboratory Co of America (NYSE:LH) Releases FY24 Earnings Guidance

Laboratory Co. of America (NYSE:LH – Get Free Report) updated its FY24 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $14.30-$15.40 for the period, compared to the consensus estimate of $14.62. Wall Street Analyst Weigh In LH has been the topic of several research reports. Barclays initiated coverage on Laboratory […]

Analysts Set Laboratory Co of America Holdings (NYSE:LH) Target Price at $242 09

Shares of Laboratory Co. of America Holdings (NYSE:LH – Get Free Report) have earned a consensus rating of “Moderate Buy” from the ten brokerages that are currently covering the company, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The […]

Laboratory Co of America (NYSE:LH) Rating Reiterated by Truist Financial

Laboratory Co. of America (NYSE:LH – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at Truist Financial in a note issued to investors on Friday, Benzinga reports. They presently have a $270.00 price objective on the medical research company’s stock. Truist Financial’s price target would indicate a potential upside of […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.